Alleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized rodent models

Endocrinology

Volumn 148, Issue 3, 2007, Pages 1376-1383

  Deecher, Darlene C ^a   Alfinito, Peter D ^a   Leventhal, Liza ^a   Cosmi, Scott ^a   Johnston, Grace H ^a   Merchenthaler, Istvan ^a   Winneker, Richard ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESVENLAFAXINE; MORPHINE; NALOXONE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE DISORDER; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; FEMALE; HYPOTHALAMUS; LONG TERM CARE; MENOPAUSE; NEUROBIOLOGY; NONHUMAN; OVARIECTOMY; PREOPTIC AREA; PRIORITY JOURNAL; SINGLE DRUG DOSE; SKIN TEMPERATURE; TELEMETRY; THERMOREGULATION; VASOMOTOR DISORDER;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BODY TEMPERATURE REGULATION; CYCLOHEXANOLS; DRUG EVALUATION, PRECLINICAL; ETHINYL ESTRADIOL; FEMALE; MODELS, ANIMAL; MORPHINE DEPENDENCE; NOREPINEPHRINE; OVARIECTOMY; PREOPTIC AREA; RATS; SEROTONIN ANTAGONISTS; TELEMETRY;

EID: 33847078095     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1163     Document Type: Article

References (42)

1. Hensel H 1973 Neural processes in thermoregulation. Physiol Rev 53:948-1017
2. McKinlay SM, Jefferys M 1974 The menopausal syndrome. Br J Prev Soc Med 28:108-115
3. Erlik Y, Meldrum DR, Judd HL 1982 Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol 59:403-407
4. Bachmann GA 2005 Menopausal vasomotor symptoms: a review of causes, effects and evidence-based treatment options. J Reprod Med 50:155-165
5. McEwen B, Alves S 2006 Estrogen actions in the central nervous system. Endocr Rev 20:279-307
6. Rybaczyk LA, Bashaw MJ, Pathak DR, Moody SM, Gilders RM, Holzschu DL 2005 An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Women's Health 5:12
7. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA 2002 Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 20:1578-1583
8. Stearns V, Isaacs C, Rowland J, Crawford J, Ellis MJ, Kramer R, Lawrence W, Hanfelt JJ, Hayes DF 2000 A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol 11:17-22
9. Weitzner MA, Moncello J, Jacobsen PB, Minton S 2002 A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 23:337-345
10. Stearns V, Beebe KL, Iyengar M, Dube E 2003 Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 289:2827-2834
11. Suvanto-Luukkonen E, Koivunen R, Sundstrom H, Bloigu R, Karjalainen E, Haiva-Mallinen L, Tapanainen JS 2005 Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 12:18-26
12. Loprinzi CL, Pisansky TM, Fonseca R, Sloan JA, Zahasky KM, Quella SK, Novotny PJ, Rummans TA, Dumesic DA, Perez EA 1998 Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 16:2377-2381
13. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, Novotny PJ, Dakhil SR, Rodger K, Rummans TA, Christensen BJ 2000 Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356:2059-2063
14. Deecher DC, Beyer CE, Johnston G, Bray J, Shah S, Abou-Gharbia M, Andree TH 2006 Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther 318:657-665
15. Alfinito PD, Chen X, Huselton C, Deecher DC 2006 Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague-Dawley rats. Brain Res 1098:71-78
16. Lucki I, O'Leary OF 2004 Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs. J Clin Psychiatry 65(Suppl 4):11-24
17. Simpkins JW, Katovich MJ, Song IC 1983 Similarities between morphine withdrawal in the rat and the menopausal hot flush. Life Sci 32:1957-1966
18. Berendsen HHG, Weekers AHJ, Kloosterboer HJ 2001 Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats. Eur J Pharmacol 419:47-54
19. Merchenthaler I, Funkhouser JM, Carver JM, Lundeen SG, Ghosh K, Winneker RC 1998 The effect of estrogens and antiestrogens in a rat model for hot flush. Maturitas 30:307-316
20. Sipe K, Leventhal L, Burroughs K, Cosmi S, Johnston GH, Deecher DC 2004 Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction. Brain Res 1028:191-202
21. Leventhal L, Cosmi S, Deecher D 2005 Effect of calcium channel modulators on temperature regulation in ovariectomized rats. Pharmacol Biochem Behav 80:511-520
22. Katovich MJ, Simpkins JW, Berglund LA, O'Meara J 1986 Regional skin temperature changes in a rat model for the menopausal hot flush. Maturitas 8:67-76
23. Harris RA, Loh HH, Way EL 1976 Antinociceptive effects of lanthanum and cerium in nontolerant and morphine tolerant-dependent animals. J Pharmacol Exp Ther 196:288-297
24. Schnur P, Espinoza M, Flores R, Ortiz S, Vallejos S, Wainwright M 1992 Blocking naloxone-precipitated withdrawal in rats and hamsters. Pharmacol Biochem Behav 43:1093-1098
25. Suzuki T, Fukagawa Y, Misawa M 1990 Enhancement of morphine withdrawal signs in the rat after chronic treatment with naloxone. Eur J Pharmacol 178:239-242
26. Maswood N, Cosmi S, Alfinito PD, Leventhal L, Deecher DC, The role of the selective serotonin reuptake inhibitor fluoxetine in temperature regulation in ovariectomized rat models. Neuroendocrinology, in press
27. Pawlyk AC, Cosmi S, Alfinito PD, Maswood N, Deecher DC 2006 Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation. Brain Res 1123:135-144
28. Paxinos G, Watson C 1998 The rat brain in stereotaxic coordinates. San Diego: Academic Press
29. Cryan JF, Mombereau C, Vassout A 2005 The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29:571-625
30. Dekeyne A 2005 Behavioural models for the characterisation of established and innovative antidepressant agents. Therapie 60:477-484
31. Hascoet M, Bourin M, Colombel MC, Fiocco AJ, Baker GB 2000 Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice. Pharmacol Biochem Behav 65:339-344
32. Muth EA, Moyer JA, Haskins JT, Andree TH, Husbands GEM 1991 Biochemical, neurophysiological, and behavioral effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxine. Drug Dev Res 23:191-199
33. Bethea CL, Lu NZ, Gundlah C, Streicher JM 2002 Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23:41-100
34. Klink R, Robichaud M, Debonnel G 2002 Gender and gonadal status modulation of dorsal raphe nucleus serotonergic neurons. Part I: effects of gender and pregnancy. Neuropharmacology 43:1119-1128
35. Panek DU, Dixon WR 1986 Effect of continuous intraventricular estrogen or catechol estrogen treatment on catecholamine turnover in various brain regions. J Pharmacol Exp Ther 236:646-652
36. Pau KY, Hess DL, Kohama S, Bao J, Pau CY, Spies HG 2000 Oestrogen upregulates noradrenaline release in the mediobasal hypothalamus and tyrosine hydroxylase gene expression in the brainstem of ovariectomized rhesus macaques. J Neuroendocrinol 12:899-909
37. Gonzales GF, Carrillo C 1993 Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas 17:23-29
38. Dawson LA, Nguyen HQ, Geiger A 1999 Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Neuropharmacology 38:1153-1163
39. Beyer CE, Boikess S, Luo B, Dawson LA 2002 Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J Psychopharmacol 16:297-304
40. Deecher DC 2005 Physiology of thermoregulatory dysfunction and current approaches to the treatment of vasomotor symptoms. Expert Opin Investig Drugs 14:435-448
41. McEwen B 2002 Estrogen actions throughout the brain. Recent Prog Horm Res 57:357-384
42. Abdelmawla AH, Langley RW, Szabadi E, Bradshaw CM 1999 Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline-and methoxamine-evoked constriction of the dorsal hand vein. Br J Clin Pharmacol 48:345-354